277 related articles for article (PubMed ID: 15955677)
1. Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology.
Rehm J; Room R; van den Brink W; Kraus L
Eur Neuropsychopharmacol; 2005 Aug; 15(4):389-97. PubMed ID: 15955677
[TBL] [Abstract][Full Text] [Related]
2. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology.
Rehm J; Room R; van den Brink W; Jacobi F
Eur Neuropsychopharmacol; 2005 Aug; 15(4):377-88. PubMed ID: 15925491
[TBL] [Abstract][Full Text] [Related]
3. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study.
Ringen PA; Melle I; Birkenaes AB; Engh JA; Faerden A; Jónsdóttir H; Nesvåg R; Vaskinn A; Friis S; Larsen F; Opjordsmoen S; Sundet K; Andreassen OA
Acta Psychiatr Scand; 2008 Feb; 117(2):133-8. PubMed ID: 18081921
[TBL] [Abstract][Full Text] [Related]
4. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.
Wittchen HU; Jacobi F
Eur Neuropsychopharmacol; 2005 Aug; 15(4):357-76. PubMed ID: 15961293
[TBL] [Abstract][Full Text] [Related]
5. Capture-recapture estimates of problem drug use and the use of simulation based confidence intervals in a stratified analysis.
Gemmell I; Millar T; Hay G
J Epidemiol Community Health; 2004 Sep; 58(9):758-65. PubMed ID: 15310802
[TBL] [Abstract][Full Text] [Related]
6. Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Hasin DS; Hatzenbueler M; Smith S; Grant BF
Drug Alcohol Depend; 2005 Oct; 80(1):117-23. PubMed ID: 16157234
[TBL] [Abstract][Full Text] [Related]
7. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of panic disorder and agoraphobia in Europe.
Goodwin RD; Faravelli C; Rosi S; Cosci F; Truglia E; de Graaf R; Wittchen HU
Eur Neuropsychopharmacol; 2005 Aug; 15(4):435-43. PubMed ID: 15925492
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Lynskey MT; Agrawal A
Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
[TBL] [Abstract][Full Text] [Related]
10. Impact of substance-induced and general medical condition exclusion criteria on the prevalence of common mental disorders as defined by the CIDI.
Sunderland M; Slade T; Anderson TM; Peters L
Aust N Z J Psychiatry; 2008 Oct; 42(10):898-904. PubMed ID: 18777235
[TBL] [Abstract][Full Text] [Related]
11. Projecting mental disorder prevalence from national surveys to populations-of-interest--an illustration using ECA data and the U. S. Army.
Messer SC; Liu X; Hoge CW; Cowan DN; Engel CC
Soc Psychiatry Psychiatr Epidemiol; 2004 Jun; 39(6):419-26. PubMed ID: 15205725
[TBL] [Abstract][Full Text] [Related]
12. Cross-generational effects on gender differences in psychoactive drug abuse and dependence.
Holdcraft LC; Iacono WG
Drug Alcohol Depend; 2004 May; 74(2):147-58. PubMed ID: 15099658
[TBL] [Abstract][Full Text] [Related]
13. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia.
Hickman M; Hope V; Platt L; Higgins V; Bellis M; Rhodes T; Taylor C; Tilling K
Drug Alcohol Rev; 2006 Mar; 25(2):131-40. PubMed ID: 16627302
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the latent class structure of cannabis problems among adult men and women who have used cannabis repeatedly.
Grant JD; Scherrer JF; Neuman RJ; Todorov AA; Price RK; Bucholz KK
Addiction; 2006 Aug; 101(8):1133-42. PubMed ID: 16869843
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse in hospitalized psychiatric patients.
Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
[TBL] [Abstract][Full Text] [Related]
16. Common psychiatric disorders over a lifetime: age of onset, risk and treatment contact in the Nigerian survey of mental health and wellbeing.
Gureje O; Uwakwe R; Udofia O; Wakil A; Adeyemi O; Enyidah N
Afr J Med Med Sci; 2008 Sep; 37(3):207-17. PubMed ID: 18982812
[TBL] [Abstract][Full Text] [Related]
17. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
[TBL] [Abstract][Full Text] [Related]
19. Adolescent substance abuse and psychiatric comorbidities.
Deas D
J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
[TBL] [Abstract][Full Text] [Related]
20. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
Chung T; Martin CS
J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
